MBMasoud Bitaraf

Masoud Bitaraf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masoud Bitaraf has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 3β-HSD1–Mediated Steroid Back-Conversion Maintains Androgen Signaling in Prostate Cancer

    by Masoud Bitaraf, Mohammad Alyamani, Nikou Fotouhi, Jinyuan Shi, Ziqi Zhu, Yoon-Mi Chung, Jennifer Freedman, Daniel J. George, Nima Sharifi

    Dihydrotestosterone (DHT), the principal driver of prostate cancer, is inactivated via reduction of its 3-keto group to a 3β-hydroxyl (3β-OH). 3β-Hydroxysteroid dehydrogenase type 1 (3β-HSD1), encoded by HSD3B1, catalyzes 3β-OH oxidation and is stabilized by an adrenal-permissive germline variant, thereby enhancing androgen biosynthesis. In this study, we tested whether 3β-HSD1 maintains androgen receptor (AR) signaling by back-converting the inactive metabolite 3β-androstanediol (3β-diol) to DHT and whether it similarly oxidizes the abiraterone (Abi) metabolite 3β-OH-5α-Abi to 3-keto-5α-Abi, a weak AR agonist. Using HSD3B1 overexpression and knockout in vitro models, we quantified steroid interconversion by mass spectrometry and AR-responsive gene expression by quantitative real-time PCR and RNA sequencing following 3β-diol exposure. HSD3B1 overexpression efficiently enabled the conversion of 3β-diol to DHT and 3β-OH-5α-Abi to 3-keto-5α-Abi. In C4-2 prostate cancer cells, 3β-diol–derived DHT regeneration and subsequent AR gene induction were blocked by the 3β-HSD1 inhibitor trilostane or abolished by HSD3B1 knockout. Clinically, in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (CRPC) treated with Abi, apalutamide, and prednisone in the PANTHER trial, men harboring the adrenal-permissive HSD3B1 genotype showed significantly greater serum depletion of 3β-OH-5α-Abi. These findings demonstrate that 3β-HSD1–mediated steroid back-conversion can maintain intratumoral androgens, providing further mechanistic insight into the poor outcomes associated with the adrenal-permissive HSD3B1 genotype and highlighting 3β-HSD1 as a critical therapeutic target in prostate cancer. Implications: 3β-HSD1–mediated back-conversion of inactivated androgens (3β-diol→DHT) and Abi metabolites (3β-OH-5α-Abi→3-keto-5α-Abi) regenerates AR-active ligands, supporting sustained AR signaling and motivating 3β-HSD1 targeting and HSD3B1 genotype–informed treatment strategies in CRPC.


  • Clinical Outcomes of Stem Cell Therapy in Dogs With Keratoconjunctivitis Sicca; A Systematic Review and Meta‐Analysis

    by Mojtaba Jafari Taheri, Masoud Bitaraf, Meysam Behtari, Saman Behboodi Tanourlouee

    Background: Keratoconjunctivitis sicca (KCS) results from a deficiency in the pre‐corneal tear film, causing persistent ocular discomfort and a predisposition to ocular surface diseases. Current treatments, including topical lacrimostimulants and lacrimomimetics, primarily offer symptomatic relief without restoring lacrimal gland function. Mesenchymal stem cell (MSC) therapy, with its regenerative and immunomodulatory properties, has been investigated in preclinical and veterinary studies but remains critically underexplored for its clinical relevance in treating KCS. Methods: A systematic review was conducted on April 24, 2024, using Medline, Embase, Web of Science, and CABI databases. Studies evaluating MSC therapy in dogs and cats with KCS were included. Data collected included demographic information, baseline and post‐treatment Schirmer tear test (STT) values, and ocular symptoms such as discharge, conjunctival hyperemia, and corneal changes. The risk of bias was assessed using validated tools, and the quality of evidence was graded using the Oxford Centre for Evidence‐Based Medicine (OCEBM). Statistical analyses were performed with STATA to compare STT values at baseline and after 1‐ and 6‐month follow‐ups. Results: Six studies involving 151 eyes from 98 dogs were included. Studies demonstrated low to moderate risk of bias, and evidence quality was graded as level C. MSC therapy significantly increased tear production and improved ocular comfort, with mean STT increases of 0.68 mm/min at 1 month and 1.51 mm/min at 6 months. Conclusion: MSC therapy offers statistically significant improvements in tear production in dogs with KCS and is considered a safe treatment option. However, the modest clinical significance highlights the need for further research to confirm its efficacy.


  • Open Access

    Phosphodiesterase‑5 inhibitors and Alzheimer’s disease; a meta‑analysis on clinical studies

    by Saman Behboodi Tanourlouee, Parham TorabiNavid, Ali Vaezi, Mina Ghorbanpour, Mir Saeed Yekaninejad, Erfan Amini, Masoud Bitaraf

    To evaluate the potential therapeutic benefits of phosphodiesterase-5 inhibitors (PDE5Is) on Alzheimer’s disease (AD), electronic databases Embase, Scopus, and Medline were systematically searched from inception to March 18th, 2024. Studies assessing the association between the use of PDE5Is and AD incidence were included. Random-effects model of restricted maximum likelihood estimator was used to pool data. Seven studies were reviewed comprising 4,833,558 individuals, of which 348,546 received treatment with one of the PDE5Is. Pooled hazard ratios (HR) for AD incidence, comparing PDE5Is with no drug use (HR = 0.47, 95% CI 0.26–0.82, p-value: 0.01), and PDE5Is with no drug or drugs not in trial for AD (HR = 0.41, 95% CI 0.33–0.52, p-value: <0.01) were calculated. Synthesized evidence indicates PDE5Is administration is associated with AD risk reduction, supporting conduct of phase 3 clinical trials.


  • Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy

    by Abolfazl Salari, Mohammadreza Ghahari, Masoud Bitaraf, Elahe Samiee Fard, Mojtaba Haddad, Seyed Ali Momeni, Seyed Hassan Inanloo, Parichehr Ghahari, Mohamoud Mohamed Mohamoud, Maryam Mohamadzadeh, et al.


  • Elevated periprostatic androgens, sneaky testosterone and its implications

    by Masoud Bitaraf, Ranjith Ramasamy, Sanoj Punnen, Nima Sharifi

    A subset of men with prostate cancer have elevated periprostatic androgens compared with levels in peripheral blood (termed the sneaky T phenomenon), which are associated with poor clinical outcomes after radical prostatectomy. These androgens are of testicular origin and reach the prostate, presumably through venous shunting. Varicocele physiology is accompanied by increased hydrostatic pressure within the pelvic venous system, providing a theoretical mechanistic explanation for the sneaky T phenomenon. These observations suggest a potential role for varicocele in contributing to prostate cancer pathophysiology through sneaky T, which if proved, could be a further indication for varicocele repair. Sneaky T can help to explain the differences in the natural history of benign or malignant prostatic diseases between individuals and could be a tool when deciding on the therapeutic course to take.


  • Open Access

    A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-Based Therapies with a Focus on the Registered Clinical Trials

    by Negin Mahmoudi, Negar Mohammadi Ganjaroudi, Alireza Soltani Khaboushan, Elham Ahmadi, Masoud Bitaraf, Asma Laleh, Shayesteh Mehdinejadiani, Masoumeh Majidi Zolbin

    The emergence of SARS-CoV-2 has led to a concerning global pandemic. The severity of COVID-19 symptoms may be enhanced due to underlying medical conditions. Several studies have demonstrated that severe COVID-19 infection can lead to innate and adaptive immune dysregulation, hypercytokinemia, as well as the formation of fibro myxoid exudate in the respiratory alveoli, ultimately resulting in pulmonary fibrosis and ARDS as the leading causes of mortality and morbidity. Currently, there is a widespread global endeavor to find efficient drugs or vaccines to manage COVID-19. Although some FDA-approved treatments have been introduced for COVID-19, alternative therapies might decrease mortality rates. Various sources of stem cell-derived exosomes, pluripotent stem cells, and mesenchymal stem cells as cell-based therapies have been applied to moderate to severe COVID-19 patients with ARDS, leading to positive results. Cell-based therapies can probably inhibit tissue remodeling and subsequent end-organ damage by modulating the cytokine cascades and cellular apoptosis. The present review aims to discuss the advantages of stem cell-based therapies in the treatment of COVID-19 patients and the possible challenges associated with their application.

  • Open Access

    Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review

    by Masoud Bitaraf, Mahmood Ghafoori Yazdi, Erfan Amini

    Diagnosis and risk stratification are cornerstones of therapeutic decisions in the management of patients with upper tract urothelial carcinoma (UTUC). Diagnostic modalities provide data that can be integrated, to provide nomograms and stratification tools to predict survival and adverse outcomes. This study reviews cytology, ureterorenoscopy and the novel tools and techniques used with it (including photodynamic diagnosis, narrow-band imaging, optical coherence tomography, and confocal laser endomicroscopy), and biopsy. Imaging modalities and novel biomarkers are discussed in another article. Patient- and tumor-related prognostic factors, their association with survival indices, and their roles in different scores and predictive tools are discussed. Patient-related factors include age, sex, ethnicity, tobacco consumption, surgical delay, sarcopenia, nutritional status, and several blood-based markers. Tumor-related prognosticators comprise stage, grade, presentation, location, multifocality, size, lymphovascular invasion, surgical margins, lymph node status, mutational landscape, architecture, histologic variants, and tumor-stroma ratio. The accuracy and validation of pre-operative predictive tools, which incorporate various prognosticators to predict the risk of muscle-invasive or non-organ confined disease, and help to decide on the surgery type (radical nephroureterectomy, or kidney-sparing procedures) are also investigated. Post-operative nomograms, which help decide on adjuvant chemotherapy and plan follow-up are explored. Finally, a revision of the current stratification of UTUC patients is endorsed.


  • Open Access

    Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models

    by Masoud Bitaraf, Samad Muhammadnejad, Ashkan Azimzadeh, Saman Behboodi Tanourlouee, Erfan Amini, Masoumeh Majidi Zolbin, Abdol‐Mohammad Kajbafzadeh

    BackgroundBladder cancer poses a great burden on society and its high rate of recurrence and treatment failure necessitates use of appropriate animal models to study its pathogenesis and test novel treatments. Orthotopic models are superior to other types since they provide a normal microenvironment. Four methods are described for developing bladder cancer models inside the animal's bladder. Direct intramural injection is one of these methods and is widely used. However, its efficacy in model development has not yet been studied. We aimed to evaluate the efficacy and success rate of the direct intramural injection method of developing an orthotopic model for the study of bladder cancer. MethodTumor cell lines were prepared in four microtubes. Aliquots of 200 x 10(3) cells were injected through a 27 gauge needle into the ventral wall of the bladders of 4 male and 4 female BALB/c mice following a midline 1 cm laparotomy incision. In addition, 1 million cells from each microtube were injected into the flanks of control mice. To prevent infection and alleviate pain, 5 mg/kg enrofloxacin and 2.5 mg/kg flunixin meglumine, respectively, were injected subcutaneously. ResultsTumors formed in all mice, resulting in 100% take rate and zero post-operation mortality. Surgery time was <= 15 min per mouse. In two mice, tumors were found in the peritoneal space as well. ConclusionDirect intramural injection is a rapid, reliable, and reproducible method for developing orthotopic models of bladder cancer. It can be done on both male and female mice and only requires readily available surgical tools. However, needle track can result in cell spillage and peritoneal tumors.


  • Open Access

    COVID-19 clinical manifestations on different gender reproductive system

    by Masoud Bitaraf, Yekta Rahimi, Reza Jafari, Fereshteh Aliakbari, Layla Shojaie, Fatemeh Saleh, Fatemeh Rezaei-Tazangi, Masoumeh Majidi Zolbin

    Coronavirus disease 2019 (COVID-19) is a major threat to world health and safety, making it the primary concern of global community that requires immediate preventive measures. Several organs are affected by this disease simultaneously with possible long-lasting sequelae. Disease pathogenesis is influenced by, the type of virus and its mutation, the number of viruses, individual’s immune system and their age, gender, nutritional status, homeostasis between the immune, nervous and endocrine systems, and also physical condition. All of these factors play a role in the onset, duration, severity, and recurrence of the disease. Since the exact mechanism of infection with this virus is not fully understood, in this study we aimed to investigate its effects on the reproductive system in male and female as well as pregnancy outcome.